Gujarat Terce Laboratories Reports Net Loss Despite Revenue Growth, Settles Tax Disputes
Gujarat Terce Laboratories Limited reported a 3.93% increase in total revenue to ₹50.20 crore, with sales rising 4.58% to ₹50.20 crore. EBITDA surged 143.12% to ₹3.89 crore, improving the EBITDA margin from 3.31% to 7.75%. However, the company faced a net loss of ₹0.98 crore due to a one-time tax settlement provision of ₹3.42 crore. The company reduced its debt-to-equity ratio from 0.54 to 0.15 and achieved zero borrowing in Q4. Operational improvements included better inventory and receivables management.